IMAGE: Lung squamous cell carcinoma

Breaking News

Key: Meeting M      Journal J      Funder F

Showing releases 51-75 out of 1335.

<< < 1 | 2 | 3 | 4 | 5 | 6 | 7 > >>

Public Release: 1-Oct-2015
Neurology: Neuroimmunology & Neuroinflammation
New study removes cancer doubt for multiple sclerosis drug
Researchers from Queen Mary University of London are calling on the medical community to reconsider developing a known drug to treat people with relapsing multiple sclerosis (MS) after new evidence shows it does not increase the risk of cancer as previously thought.

Contact: Neha Okhandiar
Queen Mary, University of London

Public Release: 1-Oct-2015
European Society for Paediatric Endocrinology Annual Meeting
Link between height and cancer
Cancer risk has been found to increase with height in both Swedish men and women, according to research presented today at the 54th Annual European Society for Paediatric Endocrinology Meeting. This long-term study is the largest carried out on the association between height and cancer in both genders.

Contact: Dr. Fiona Docherty
BioScientifica Limited

Public Release: 1-Oct-2015
JAMA Oncology
Women getting BRCA testing not receiving counseling by trained genetics professionals
Most women who underwent BRCA genetic testing did not receive genetic counseling by trained genetics professionals and the lack of clinician recommendation was the most commonly reported reason in a study of commercially insured women, according to an article published online by JAMA Oncology.

Contact: Anne DeLotto Baier
The JAMA Network Journals

Public Release: 1-Oct-2015
Clinical Cancer Research
Investigational KW-0761 efficiently depletes immune system-suppressing Treg cells
In a phase Ia clinical trial, immune cells called Tregs, which can inhibit anticancer immune responses, were efficiently eliminated from the blood of patients with lung or esophageal cancer by treatment with the investigational therapeutic antibody KW-0761.
Ministry of Health, Labour, and Welfare of Japan; Ministry of Education, Culture, Sports, Science, and Technology of Japan; Japan Society for the Promotion of Science

Contact: Lauren Riley
American Association for Cancer Research

Public Release: 1-Oct-2015
Nature Communications
Major study finds 5 new genetic variants linked to brain cancer
The biggest ever study of DNA from people with glioma -- the most common form of brain cancer -- has discovered five new genetic variants associated with the disease. Researchers said their findings provided important new evidence for an inherited susceptibility to glioma, and offered potential clues for how to treat or prevent the disease.
Cancer Research UK, Wellcome Trust, DJ Fielding Medical Research Trust

Contact: Henry French
Institute of Cancer Research

Public Release: 1-Oct-2015
Lung Cancer
What is the cost of lung cancer in Germany?
With more than 50,000 newly diagnosed cases each year, lung cancer is one of the most common types of cancer in Germany. As yet, however, very few statistics are available on the care situation of lung cancer sufferers and the associated costs. Scientists at the Helmholtz Zentrum München have now analyzed comprehensive health insurance data in order to discover the cost of the disease and which treatment has the best prognosis. Their findings have been published in the medical journal Lung Cancer.

Contact: Dr. Larissa Schwarzkopf
Helmholtz Zentrum München - German Research Center for Environmental Health

Public Release: 1-Oct-2015
Genome Research
New method to predict increased risk of non-familial breast cancer
By detecting cancer at an early stage, or even predicting who has an increased risk of being affected, the possibilities to treat the disease can be radically improved. In an international study led from Uppsala University the researchers have discovered that apparently healthy breast cells contain genetic aberrations that can be associated with an increased risk for non-familial breast cancer. The results have been published in the journal Genome Research.

Contact: Jan Dumanski
Uppsala University

Public Release: 30-Sep-2015
European Society for Paediatric Endocrinology Annual Meeting
Scientists create insulin-producing cells that may treat diabetes
A new technique to produce cells with insulin-secretion capabilities has been developed, according to research presented today at the 54th Annual European Society for Paediatric Endocrinology Meeting. The technique could be further developed to be used in the transplantation for patients with type 1 diabetes.

Contact: Fiona Docherty
BioScientifica Limited

Public Release: 30-Sep-2015
EMBO Reports
Scientists discover how to trap cancer cells before they spread
Researchers at the Francis Crick Institute and the University of Copenhagen have discovered a new way to potentially 'fence in' a tumor and help stop cancer cells spreading.
Cancer Research UK, FEBS, Novo Nordisk Foundation, Danish Cancer Society, Danish Council for Independent Research, Innovation Fund Denmark and Wellcome Trust

Contact: Press Office
Cancer Research UK

Public Release: 30-Sep-2015
Experimental cancer drug shows therapeutic promise in mouse models of multiple sclerosis
An experimental drug originally identified in a National Cancer Institute library of chemical compounds as a potential therapy for brain and basal cell cancers improves the symptoms of mice with a form of the debilitating neurological disorder multiple sclerosis (MS), according to new research from NYU Langone Medical Center.

Contact: David March
NYU Langone Medical Center / New York University School of Medicine

Public Release: 30-Sep-2015
'Avatars' reveal new genetic sources of drug response in late-stage colorectal therapy
Using pieces of human tumors grafted into mice, a team led by Johns Hopkins Kimmel Cancer Center researchers and their colleagues from the University of Torino has identified new mutations in six genes related to drug resistance and sensitivity in late-stage colorectal cancer.

Contact: Vanessa Wasta
Johns Hopkins Medicine

Public Release: 30-Sep-2015
Journal of Molecular Diagnostics
Study lays groundwork for blood test to aid in the detection and monitoring of myeloma
Only 5 percent of myeloma cases are stage I when diagnosed. One reason may be the lack of good routine screening tests to identify patients who will progress to myeloma. A new study in The Journal of Molecular Diagnostics found that abnormal levels of microRNAs (miRNAs) detected in the bone marrow of multiple myeloma patients may also be detectable in peripheral blood, and their measurement may be a way to both mark myeloma onset and track its progression from earlier asymptomatic stages.
NIH/Intramural Research Program, NIH/National Cancer Institute

Contact: Eileen Leahy
Elsevier Health Sciences

Public Release: 30-Sep-2015
Genome Research
Researchers show that genetic background regulates tumor differences
Researchers from Uppsala University, Sweden, and the Broad Institute, USA, have identified both similarities and differences between a single tumor type in multiple dogs breeds; a finding they believe parallels the situation in the cancer of human patients.

Contact: Ingegerd Elvers
Uppsala University

Public Release: 30-Sep-2015
EMBO Reports
Scientists discover how to trap cancer cells before they spread
Researchers at the University of Copenhagen and the Francis Crick Institute have discovered a new way to potentially 'fence in' a tumor and help stop cancer cells spreading, according to a study printed in EMBO Reports on Oct. 1 2015.
Novo Nordisk Foundation, Cancer Research UK, FEBS, Danish Cancer Society, Danish Council for Independent Research, Innovation Fund Denmark, Wellcome-Trust

Contact: Janine Erler
University of Copenhagen, Biotech Research & Innovation Centre

Public Release: 30-Sep-2015
Journal of the National Cancer Institute
Doctors often overtreat with radiation in late-stage lung cancer
Almost half of patients with advanced lung cancer receive more than the recommended number of radiation treatments to reduce their pain, according to a new study published in the Journal of the National Cancer Institute.

Contact: Sharon Parmet
University of Illinois at Chicago

Public Release: 30-Sep-2015
Molecular Biology of the Cell
Scientists refine model to predict dangerous errors in cell division
A team of Virginia Tech researchers has refined a mathematical model that simulates the impact of genetic mutations on cell division -- a step that could provide insight into errors that produce and sustain harmful cells, such as those found in tumors.
National Institutes of Health

Contact: Tiffany Trent
Virginia Tech

Public Release: 30-Sep-2015
New England Journal of Medicine
Reduced-nicotine cigarettes decreased dependence and frequency of smoking: NEJM study
Reduced-nicotine cigarettes were beneficial in reducing nicotine exposure and dependence, and also the number of cigarettes smoked per day, when compared with standard-nicotine cigarettes in a six-week study published in the New England Journal of Medicine.
NIH/National Institute on Drug Abuse, Food and Drug Administration Center for Tobacco Products

Contact: Craig Boerner
Vanderbilt University Medical Center

Public Release: 30-Sep-2015
Canadian Journal of Public Health
Canadian magazines miss the mark on skin cancer messages
Canadian magazines are sending women mixed messages about skin cancer and tanning, according to new University of Waterloo research. The study, published in the Canadian Journal of Public Health and funded by the Canadian Institutes of Health Research and the Social Sciences and Humanities Research Council of Canada, found that magazines promote a tanned look and provide women with limited information on risk factors and early detection for skin cancer.
Canadian Institutes of Health Research, Social Sciences and Humanities Research Council of Canada

Contact: Nick Manning
University of Waterloo

Public Release: 29-Sep-2015
International Journal of Medical Engineering and Informatics
Risk factors for prostate cancer
New research suggests that age, race and family history are the biggest risk factors for a man to develop prostate cancer, although high blood pressure, high cholesterol, vitamin D deficiency, inflammation of prostate, and vasectomy also add to the risk. In contrast, obesity, alcohol abuse, and smoking show a negative association with the disease. Details are reported in the International Journal of Medical Engineering and Informatics.

Contact: Albert Ang
Inderscience Publishers

Public Release: 29-Sep-2015
Journal of Clinical Pathology
Intratumor morphological heterogeneity of cancer is not related to chromosome aberrations
Intratumor morphological heterogeneity (diversity) of breast cancer is not related to chromosome aberrations. This conclusion was made based on the study of one case with aggressive variant of breast cancer -- invasive micropapillary carcinoma by researchers from Tomsk State University, Tomsk Cancer Research Institute, and Institute of Medical Genetics.

Contact: Tatiana Arsenyeva
National Research Tomsk State University

Public Release: 29-Sep-2015
Advanced Materials
Researchers disguise drugs as platelets to target cancer
Researchers have for the first time developed a technique that coats anticancer drugs in membranes made from a patient's own platelets, allowing the drugs to last longer in the body and attack both primary cancer tumors and the circulating tumor cells that can cause a cancer to metastasize. The work was tested successfully in an animal model.
National Institutes of Health

Contact: Matt Shipman
North Carolina State University

Public Release: 29-Sep-2015
Nano Letters
Sniffing out cancer with improved 'electronic nose' sensors
Scientists have been exploring new ways to 'smell' signs of cancer by analyzing what's in patients' breath. In ACS' journal Nano Letters, one team now reports new progress toward this goal. The researchers have developed a small array of flexible sensors, which accurately detect compounds in breath samples that are specific to ovarian cancer.

Contact: Michael Bernstein
American Chemical Society

Public Release: 29-Sep-2015
Journal of Environmental Health
Arsenic found in many US red wines, but health risks depend on total diet
A new UW study that tested 65 wines from America's top four wine-producing states -- California, Washington, New York and Oregon -- found all but one have arsenic levels that exceed US drinking water standards. But health risks from that naturally-occurring toxic element depend on how many other high-arsenic foods and beverages, such as apple juice, rice, or cereal bars, an individual person eats.

Contact: Jennifer Langston
University of Washington

Public Release: 29-Sep-2015
Trends in Cancer
Eight big questions in cancer research
Leading cancer researchers address eight of the 'big questions' facing the field as part of the inaugural issue of Trends in Cancer, published by Cell Press.

Contact: Joseph Caputo
Cell Press

Public Release: 29-Sep-2015
Population Health Management
Underdetection, not overdiagnosis, is the real problem in breast cancer screening
While screening mammography has a well-established history of reducing death from breast cancer and enabling earlier detection of breast disease, questions regarding overtreatment and overdiagnosis have entered the screening debate. A new review article discusses the topics of overdiagnosis and overtreatment and the role of providers and technology to address the issues in the context of population health. The article appears in a new supplement to Population Health Management.

Contact: Kathryn Ryan
Mary Ann Liebert, Inc./Genetic Engineering News

Showing releases 51-75 out of 1335.

<< < 1 | 2 | 3 | 4 | 5 | 6 | 7 > >>

  Search News Releases